NCT03379181View on ClinicalTrials.gov

Thermogenesis in Hyperthyroidism and Effect of Anti-Adrenergic Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 18, 2017

Primary Completion Date

February 12, 2020

Study Completion Date

February 12, 2020

Conditions
Hyperthyroidism
Interventions
DRUG

Propranolol

Patients receive a single dose of 80 mg propranolol p.o.

Trial Locations (1)

4031

University Hospital Basel, Department of Endocrinology, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03379181 - Thermogenesis in Hyperthyroidism and Effect of Anti-Adrenergic Therapy | Biotech Hunter | Biotech Hunter